The federal government edged closer to emergency use approval of the Pfizer COVID-19 vaccine for children ages 5-11 following a vote on Tuesday by the Food and Drug Administration to recommend the shot for this age group in advance of a Centers for Disease Control and Prevention meeting next week. With the latest action laying the groundwork for the vaccine to become available to children 5 and older in early November, Rutgers faculty and staff share reasons for why they’ll vaccinate their children. To read the full story.